Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT2 | P31751 | 3/20 | 1.00 |
| ▸ | KDR | P35968 | 13/20 | 0.72 |
| ▸ | FGFR1 | P11362 | 11/20 | 0.72 |
| ▸ | PDGFRB | P09619 | 10/20 | 0.72 |
| ▸ | EGFR | P00533 | 4/20 | 0.70 |
| ▸ | FLT3 | P36888 | 6/20 | 0.68 |
| ▸ | AURKB | Q96GD4 | 4/20 | 0.68 |
| ▸ | AURKA | O14965 | 4/20 | 0.68 |
| ▸ | FLT4 | P35916 | 3/20 | 0.68 |
| ▸ | RET | P07949 | 2/20 | 0.68 |
| ▸ | FLT1 | P17948 | 2/20 | 0.68 |
| ▸ | MAP4K2 | Q12851 | 2/20 | 0.68 |
| ▸ | STK3 | Q13188 | 2/20 | 0.68 |
| ▸ | GAK | O14976 | 1/20 | 0.68 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.68 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.68 |
| ▸ | LATS1 | O95835 | 1/20 | 0.68 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.68 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.68 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5728442 | 1.00 | AKT2 (1.00) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL5728707 | 0.86 | AKT2 (0.75) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL5728703 | 0.86 | AKT2 (0.75) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL4415638 | 0.85 | KDR (0.78) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL4415642 | 0.85 | KDR (0.78) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL4405035 | 0.85 | KDR (0.81) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL4405036 | 0.85 | KDR (0.81) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL5727887 | 0.84 | AKT2 (1.00) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL5727889 | 0.84 | AKT2 (1.00) | AKT2KDRFGFR1PDGFRBEGFR | |
| SCHEMBL4410717 | 0.84 | KDR (1.00) | AKT2KDRFGFR1PDGFRBEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1680401-A2 | INDOLINONE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER | Schering Aktiengesellschaft (DE) | 2006-07-19 | — | — | EP | claimed |
| WO-2005040116-A2 | INDOLINONE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-05-06 | — | — | WO | claimed |
| US-20050090541-A1 | Indolinone derivatives and their use in treating disease-states such as cancer | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-04-28 | — | — | US | claimed |
| US-7105563-B2 | Indolinone derivatives and their use in treating disease-states such as cancer | SCHERING AKTIENGESELLSCHAFT (DE) | 2006-09-12 | — | — | US | disclosed |
| EP-1680401-A2 | INDOLINONE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER | Schering Aktiengesellschaft (DE) | 2006-07-19 | — | — | EP | disclosed |
| WO-2005040116-A2 | INDOLINONE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-05-06 | — | — | WO | disclosed |
| US-20050090541-A1 | Indolinone derivatives and their use in treating disease-states such as cancer | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090541-A1 | Indolinone derivatives and their use in treating disease-states such as cancer | PDK3, PDK2, PDK4 | AKT2 1359/4885KDR 2521/4885FGFR1 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.